FDA Approves RizaFilm (rizatriptan) Oral Film for the Treatment of Acute Migraine

SAINT LAURENT, Quebec, April 17, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the " Company " or " IntelGenx " ), a leader in pharmaceutical films, today announced that the U.S. Food and Drug Administration (“FDA”) has...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news